Almotriptan versus rizatriptan in patients with migraine in Spain.
To compare patient-reported use of rizatriptan 10 mg with that of almotriptan 12.5 mg per migraine attack (24 hours) in a Spanish population.One hundred twenty Spanish community pharmacies recruited patients with migraine to whom they had dispensed almotriptan and rizatriptan.In this prescription-se...
| Autores: | , , , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2003 |
| País: | España |
| Recursos: | Universidad Loyola Andalucía |
| Repositorio: | Brújula |
| OAI Identifier: | oai:repositorio.uloyola.es:20.500.12412/4934 |
| Acesso em linha: | https://hdl.handle.net/20.500.12412/4934 |
| Access Level: | acceso abierto |
| Palavra-chave: | Rizatriptan Almotriptan Migraine Triptan consumption survey |
| Resumo: | To compare patient-reported use of rizatriptan 10 mg with that of almotriptan 12.5 mg per migraine attack (24 hours) in a Spanish population.One hundred twenty Spanish community pharmacies recruited patients with migraine to whom they had dispensed almotriptan and rizatriptan.In this prescription-selected Spanish population, a significantly lower number of rizatriptan tablets were required to treat migraine attacks compared with almotriptan. |
|---|